340B HEALTH for 340B HEALTH
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); The SUSTAIN 340B Act (S.5244); Senator Bill Cassidys 340B Discussion Draft bill 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; Notice Regarding 340B Rebate Model Pilot Program; Pending introduction of Reps. Bresnahan and Dingells two-year rebate model pilot ban legislation; FY27 Appropriations legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENDALL ANNE CAIRNS | — |
| GARRETT EBERHARDT | — |
| RHEA RACHO | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.